t has been proposed that alterations in network dynamics are instrumental for development of schizophrenia [1] [2] [3] . However, it remains unclear how a neurodevelopmental circuit dysfunction is caused by altered neuronal physiology and whether such a dysfunction can be corrected during adulthood.
Deceased: Dominique Müller. *e-mail: thomas.marissal@inserm.fr; alan.carleton@unige.ch I t has been proposed that alterations in network dynamics are instrumental for development of schizophrenia [1] [2] [3] . However, it remains unclear how a neurodevelopmental circuit dysfunction is caused by altered neuronal physiology and whether such a dysfunction can be corrected during adulthood.
A specific population of inhibitory neurons, the parvalbumin interneurons (PVIs), has a key role in regulating network dynamics [4] [5] [6] [7] , and a growing body of evidence in rodents suggests that they have a causal role in neuronal dysfunctions relevant to schizophrenia [8] [9] [10] [11] . Consistent with this, mouse models in which PVI properties have been modified can reproduce some behavioral phenotypes relevant to schizophrenia 7, [12] [13] [14] [15] [16] . However, it remains unclear whether manipulating specifically PVIs during adulthood can restore altered physiology and behavior in animal models associated with a genetic risk factor identified in humans.
A specific deletion of ~30 genes on human chromosome 22, which leads to the 22q11 deletion syndrome (22q11DS), is the highest identified genetic risk factor for developing schizophrenia [17] [18] [19] . We used a genetically engineered mouse bearing a hemizygous deletion on mouse chromosome 16, termed Lgdel/+ , which replicates the chromosomal alteration of the human 22q11DS 18 . In the CA1 area of the hippocampus, mouse models of 22q11DS differ from wild-type (WT) animals with regards to their structural [20] [21] [22] and electrophysiological properties 23 , and their functional connectivity with distant brain areas 3 . We studied alterations in network dynamics and behavior in the Lgdel/+ model of the 22q11DS and developed a rescue strategy based on PVI manipulations during adulthood.
Results
Hyposynchronization of pyramidal cells in the Lgdel/+ CA1 hippocampal network in vitro. We monitored neural activity in hippocampal slice cultures using the genetically encoded calcium indicator GCaMP6s, which was expressed by CA1 neurons following adeno-associated viral (AAV) vector transfection (Fig. 1a,b) . Network dynamics were induced by bath application of carbachol (see Methods), which triggered spontaneous calcium activity in individual neurons of WT (+ /+ ) mice (Fig. 1c,d , Supplementary  Fig. 1 , and Supplementary Video 1). Similarly, individual CA1 neurons of Lgdel/+ mice exhibited spontaneous calcium activity during the duration of the recording. Neither the fraction of active neurons (Fig. 1e) , the mean frequency (Fig. 1f) , the mean amplitude ( Fig. 1g) , nor the mean duration ( Fig. 1h ) of calcium transients was significantly different between genotypes. In contrast, CA1 ensemble dynamics was altered in Lgdel/+ mice (Supplementary Video 2). Indeed, neurons were desynchronized with respect to each other, and the oscillations that we observed at a population level were reduced in Lgdel/+ mice (Fig. 1c,d ). We therefore quantified population activity and neuronal correlations and compared these quantities to data randomly shuffled in time (see Methods). This allowed us to control for the influence of neuronal coactivation occurring by chance ( Supplementary Figs. 2 and 3 ). Lgdel/+ mice displayed fewer coactive cells (Fig. 1i) , fewer occurrences of these coactivations (Fig. 1j) , and fewer correlated neurons (Fig. 1k,l ) with respect to WT animals. In summary, Lgdel/+ slices exhibited a desynchronization of the CA1 hippocampal network.
, CA1 pyramids recorded from Lgdel/+ mice had a comparable number of sEPSCs, but fewer sIPSCs, per second compared with CA1 pyramids in WT mice ( Fig. 2a-d ). In addition, we observed no differences in spontaneous postsynaptic current amplitude ( Supplementary Fig. 4a-c) , miniature EPSC (mEPSC) frequency ( Supplementary Fig. 4d ), or miniature IPSC (mIPSC) frequency (Fig. 2e) between the two genotypes. These results provide evidence that hippocampal pyramids in Lgdel/+ mice are characterized by hypoinhibition, which likely originates from the alteration of the firing activity of GABAergic neurons.
We further tested the role of PV interneurons in the hypoinhibition of pyramidal neurons by recording genetically labeled PVIs ( Fig. 2f-n ). An analysis of input/output function in current-clamp experiments revealed that CA1 PVIs were less excitable in Lgdel/+ than in WT animals when recorded in artificial cerebrospinal fluid (Fig. 2g,h) . Notably, this firing difference disappeared when GABA A , AMPA, and NMDA receptors were blocked pharmacologically (Fig. 2i) . Thus, PVI hypoexcitability may rather reflect differences in PVI synaptic inputs, rather than changes in their intrinsic properties. Supporting this hypothesis, CA1 PVIs recorded from Lgdel/+ mice received similar numbers of sEPSCs, but more sIPSCs, per second than CA1 PVI neurons recorded in WT animals ( Fig. 2j-m) . We observed no difference in spontaneous postsynaptic current amplitude ( Supplementary Fig. 4f,g ), mEPSC frequency ( Supplementary Fig. 4h ), or mIPSC frequency (Fig. 2n) . Taken together, our data indicate that CA1 pyramidal cells of Lgdel/+ mice are hypoinhibited and that PVIs are hypoexcitable.
Increasing PVI excitability restores WT-like CA1 network dynamics in Lgdel/+ mice. Could the altered network dynamics that we observed in slices be induced by PVI hypoexcitability? To address this question, we used the cell-autonomous chemogenetic approach of specifically infecting CA1 PVIs from Pvalb cre/+ ; + /+ mice with AAV, enabling the conditional expression of the inhibitory designer receptor exclusively activated by designer drug 2+ transients in the CA1 region (each circle represents the mean for a given slice, numbers of slices are indicated in parentheses). f-h, Frequency (f), amplitude (g), and duration (h) of Ca 2+ transients recorded in neurons of the CA1 area. The mean frequency did not differ significantly despite a trend for a more prominent subpopulation of neurons with low firing rate in Lgdel/+ mice compared with WT mice ( Supplementary Fig. 1a,b) . i, j, Percentage of coactive neurons above random coactivation (i) and occurrence of these coactivations (j). k, Percentage of correlated pairs of neurons above chance. l, Distributions of significant time lags in correlated pairs. Box: th percentiles, whiskers: 10-90 th percentiles, white bar: median. Statistical comparisons were done either with a two-sided Mann-Whitney test (e-k) or a two-way repeated measures ANOVA (l, interaction genotype × time lags F 20,680 = 9.95, P < 10 ) followed by Bonferroni post hoc test (l, *P < 0.05: see Supplementary Table 1 for detailed statistics). Data are presented as mean ± s.e.m. unless indicated otherwise.
(DREADD) hM4Gi, which is selectively activated by the drug clozapine-N-oxide (CNO, see Methods). Reducing PVI excitability desynchronized CA1 assemblies in WT slices (Fig. 3) .
Conversely, could hippocampal network dynamics be rescued in Lgdel/+ mice by increasing PVI excitability? First, we used a pharmacological approach by using a Neuregulin 1 peptide (NRG1P), which increases PVI excitability in WT mice 24 without altering network dynamics or behavior ( Supplementary Fig. 5 ). Second, we specifically expressed the excitatory DREADD hM3Gq in CA1 PVIs from Pvalb cre/+ ;Lgdel/+ mice. During patch-clamp recordings of hippocampal cultured slices, both strategies raised PVI excitability and restored input/output functions comparable to the ones recorded from Pvalb ;Lgdel/+ mice generated less calcium transients than PVIs from Pvalb cre/+ ;+ /+ mice during slice imaging after carbachol application. Similarly, the frequency of the calcium events recorded in PVIs from Pvalb cre/+ ;Lgdel/+ cultured slices increased during the application of NRG1 or CNO and restored frequencies comparable to the ones recorded from Pvalb cre/+ ;+ /+ mice (two-sided Mann-Whitney test, U = 241 and 248, P = 0.77 and 0.63 for NRG1P and CNO treatment, respectively; Fig. 4g,h ). Duration and amplitude were not affected by the treatments (Fig. 4i,j) .
We then tested the effect of the two treatments on CA1 network dynamics by pre-incubating hippocampal cultured slices with either NRG1P or CNO before calcium imaging. Notably, both strategies increased neuronal correlations ( by the same depolarizing step of current in CA1 PVIs recorded from Pvalb cre/+ ;Lgdel/+ mice before and after NRG1P bath application (10 nM). b, Input/output functions for CA1 PVIs recorded before and after NRG1P application (two-way repeated measures ANOVA: interaction treatment × injected current F 9,54 = 3.54 P = 0.0016; two-sided Fisher post hoc test *P < 0.05: see Supplementary Table 1 for detailed statistics). c, Summary graph of the firing frequency generated by PVIs in response to a 235-pA current step before and after NRG1P application (two-sided Wilcoxon paired test). d, Examples of spiking activity evoked by the same depolarizing step of current in CA1 PVIs recorded from Pvalb cre/+ ;Lgdel/+ expressing the excitatory DREADD hM3Gq (Pvalb hM3Gq ;Lgdel/+ ) before and after CNO bath application (1 μ M). e, Input/output functions for CA1 PVIs recorded before and after CNO application (two-way repeated measures ANOVA: interaction treatment × injected current F 9,45 = 8.2, P = 4.6 × 10
; two-sided Fisher post hoc test *P < 0.05: see Supplementary Table 1 for detailed statistics). f, Summary graph of the firing frequency generated by PVIs in response to a 235-pA current step before and after CNO application (two-sided Wilcoxon paired test). g, Examples of Ca and 74, P = 0.73 and 0.89 for NRG1P and CNO treatment, respectively; Fig. 5c ). Thus, counterbalancing the PVI hypoexcitability of Lgdel/+ mice was sufficient to extinguish the network desynchronization observed in brain slices.
Although 22q11DS is considered to be a neurodevelopmental disorder, we investigated whether the pharmacological and chemogenetic treatments described above could also be efficient in adult animals. We first performed in vivo electrophysiological recordings in the dorsal CA1 area (dCA1) of awake mice ( ;Lgdel/+ mice with an AAV that enabled the conditional expression of the DREADD hM3Gq ( Supplementary Fig. 7c ). CNO injections also significantly elevated the LFP theta power (Fig. 6a-c) . Notably, Lgdel/+ mice treated with NRG1P or CNO for 60 min no longer displayed any significant difference with the control mice (that is, WT 60 min after intraperitoneal injection of NRG1P; two-sided Mann-Whitney test; P = 0.65 and 0.48, respectively). To determine whether these results were specific to the theta frequency band, we performed a similar analysis on the delta (1-4 Hz) and gamma (30-80 Hz) frequency bands. The power of oscillations in the delta frequency band did not differ between WT and Lgdel/+ animals ( Supplementary Fig. 8a ). In contrast, the power measured in the gamma frequency range was lower in Lgdel/+ than in WT mice ( Supplementary Fig. 8b ). When pharmacological and cell-autonomous pharmacogenetic treatments were applied, the power in the gamma frequency range increased ( Supplementary Fig. 8c ).
Given that LFP analyses revealed the neural dynamics occurring at a mesoscale level, we wanted to know whether these effects are also observable at a finer scale. During the same recordings, we isolated single units and quantified their cross-correlation (see Methods). As previously reported 25 , the majority of the correlations occurred around zero-phase lag ( ± 20 ms; Fig. 6d) . To compare the different treatments, we evaluated the highest fraction of correlated neurons among all available lags for each recording. Consistent with our in vitro findings, Lgdel/+ mice had fewer correlated pairs than their WT littermates (Fig. 6e) . When NRG1P was administered to Lgdel/+ mice or CNO was injected in Pvalb cre/+ ;Lgdel/+ mice, the fraction of correlated cells increased consistently (Fig. 6f) . In summary, NRG1P injection and chemogenetic excitation of PVIs in adult animals increased the occurrence of neuronal correlations and the power of theta oscillations in awake Lgdel/+ mice.
Increasing PVI excitability restores hippocampal-dependent behavioral deficits in Lgdel/+ mice. Could the same pharmacological and chemogenetic manipulations also restore WT-like behaviors? As has been observed in various animal models of schizophrenia 26 , including the 22q11DS mouse model 21 , adult Lgdel/+ mice exhibited hyper-locomotor activity in comparison with their WT littermates in the open field test (OFT). Intra-peritoneal injections of NRG1P in Lgdel/+ mice (30-60 min before the testing) and selective excitation of dCA1 PVI expressing the hM3D DREADD led to a reduction in the distance traveled in the OFT to levels similar to the ones reached by WT littermates (two-sided Mann-Whitney test; Lgdel/+ , P = 0.15, U = 93; WT, P = 0.61, U = 57; Fig. 7a ,b; note that NRG1P had no effect on WT behavior, see Supplementary  Fig. 5i,j) . Next, we measured the acoustic startle reflex and its ; see Supplementary Table 1 pre-pulse inhibition (PPI), which are considered to be relevant biomarkers of schizophrenia 27 . As previously reported 21, 28 , we observed that Lgdel/+ mice exhibited both a higher startle response and a lower PPI than WT mice ( Supplementary Fig. 9a-c) . When either CNO or NRG1P were injected, the startle response in Lgdel/+ mice was decreased to a level comparable to the one observed in WT animals ( Supplementary Fig. 9a,b) . Moreover, when NRG1P was administrated intraperitoneally, the PPI deficit of Lgdel/+ mice was also rescued (Supplementary Fig. 9c ). In contrast, such a rescue did not occur when the dCA1 PVI excitability was enhanced chemogenetically. This result is consistent with the notion that hippocampal processing is not necessary for PPI 29 . Finally, to assess memory deficits relevant to schizophrenia 26, 30 , we used contextual fear conditioning (Fig. 7c) . As previously reported for other 22q11DS mouse models 21, 31 , Lgdel/+ mice displayed a deficit in fear memory response compared with WT mice (Fig. 7d) . The latter difference cannot be explained by a general tendency of Lgdel/+ mice to freeze less, as we observed no genotype difference in the freezing behavior during the conditioning (Supplementary Fig. 9d ). During contextual fear testing, the injection of NRG1P and the activation of hM3Gq increased the conditional response of Lgdel/+ mice to WT levels (comparison with WT values: two-sided Mann-Whitney test; NRG1P, P = 0.69, U = 72; CNO, P = 0.28, U = 57), thereby improving their hippocampal-dependent memory (Fig. 7d,e and Supplementary Fig. 5k ). In conclusion, increasing the excitability of PVI during adulthood was not only sufficient to restore CA1 network dynamics, but also restored WT-like behavior in Lgdel/+ mice.
Discussion
We tested the causal relationship between deficits at synaptic and physiological levels and anomalies in network dynamics and behavior using an animal model of the 22q11DS. Although both the cortical 32 and hippocampal networks 33 may be involved in the pathophysiology of schizophrenia and of 22q11DS, we focused our work on the latter area. Effectively, hippocampi originating from mouse models of the disorders display alterations in the properties of their synaptic and neuronal components [20] [21] [22] [23] , as well as their circuit dynamics 3, 34 . Our in vitro hippocampal preparation allowed us to identify a deficit in CA1 ensemble dynamics (Fig. 1) , which was causally linked to the reduced excitability of PVIs (Figs. 2, 3 , and 5). It also let us develop a rescue strategy based on increasing PVI excitability using either a PVI-specific chemogenetic approach or a pharmacological strategy (that is, NRG1P; Figs. 4 and 5) . Notably, the rescue strategies were further validated in vivo in adult animals. We observed a deficit in the synchronized activity of the CA1 neuronal network in awake Lgdel/+ mice, as reflected by a diminished spike correlation between neuronal pairs and a reduction in neuronal oscillations in the theta frequency range ( Fig. 6 and Supplementary Fig. 8 ). These deficits were either diminished or abolished by manipulations of PVI excitability. We also manipulated PVI excitability during various behaviors that involved hippocampal processing and that were relevant to the intellectual disabilities associated with the 22q11DS 18 ( Fig. 7) . Using the Df16/+ mouse model of 22q11DS, a previous study observed differences with WT animals in an open-field exploration, during contextual fear conditioning, and during PPI of the acoustic startle reflex 21 . Consistently, we found differences between Lgdel/+ mice and WT littermates in the same tests. We eliminated these alterations in the open-field test and during contextual fear conditioning test by modulating the excitability of dCA1 PVI using a specific chemogenetic manipulation. The same manipulation improved the startle reflex, but failed to restore the PPI observed in Lgdel/+ mice. In contrast, the systemic injection of NRG1P, which probably affected various brain regions, rescued the PPI deficit. Given that hippocampal processing is not necessary for PPI 29 , these results suggest that the recovery of PPI by NRG1P administration operates through other brain regions than the dorsal hippocampus.
Consistent with the latter assumption, it was recently reported that the schizophrenia-related circuit dysfunction and behavioral alterations observed in adult Dlx5/6 +/-mice were rescued by optogenetic activation of prefrontal cortex interneurons. However, PVI-specific manipulations were not specifically tested 7 .
In this study, we made no attempt to dissect the molecular mechanisms underlying the cellular and network alterations of the Lgdel/+ mouse model. Testing the causal relationship between each of the ~30 genes deleted in this pathology 18 and the neuronal/circuit properties would be a dauntingly long task with an uncertain outcome. Although NRG1 and its receptor Erbb4 are associated with schizophrenia in both rodents 13 and in humans 35 , none of the genes in its molecular pathway seems to be a part of the 22q11DS deletion. Other laboratories have identified an alteration of the ZDHHC8-Gsk3 pathway, which could be a neuronal substrate to the network and behavioral deficits related to the 22q11DS deletion 36, 37 . However, the rescue strategies targeting the ZDHHC8-Gsk3 pathway are efficient only during a narrow period of development and are not likely to restore the behavioral phenotypes during adulthood.
PVI dysfunction has also been observed in other animal models related to schizophrenia 7, 10, [12] [13] [14] [15] [16] . Thus, we hypothesize that different molecular mechanisms could lead to identical alterations of PVIs, which could be rescued using a strategy similar to the one presented in this study. If this hypothesis is correct, PVI neurons would represent a possible therapeutical target for various mental diseases regardless of their molecular origin. Determining the effect of PVI modulation on other genetic or drug-induced models of neuropsychiatric diseases will require further investigation. In addition, it remains unclear as to whether the impaired PVIs belong to a specific subclass of parvalbumin-expressing interneurons [38] [39] [40] [41] [42] . It is well accepted that there are different subtypes of CA1 PVIs, of which basket cells are the most abundant 38 and count for more than 70% in the CA1 stratum pyramidale 39 . To reduce the variability related to the heterogeneity of PVIs, we limited the characterization of the synaptic and electrophysiological properties of the CA1 PVI to the pyramidal layer, which may include bi-stratified 40 and axo-axonic cells 43 , two cell types related to schizophrenia 44, 45 . Given that our chemogenetic rescue strategy did not discriminate between different PVI subtypes, more specific genetic manipulations will be required to determine the relative contributions of various PVI subpopulations.
Consistent with the previous point, we made no attempt to identify the neuronal source of the increased inhibition received by PVIs located in the CA1 pyramidal cell layer of Lgdel/+ slices. This hyper-inhibition might appear paradoxical, given that PVIs, which are known to inhibit each other in the hippocampus 46 , are hypoexcitable in the mutants. However, we cannot exclude the possibility that PVIs located outside of the pyramidal cell layer, which we did not record, might be hyper-excitable in Lgdel/+ mice. Alternatively, PVIs might also receive inhibitory inputs from other classes of parvalbumin-negative interneurons 47, 48 , which are presumably hyper-excitable in Lgdel/+ mice. A recent study, which used singlecell RNA sequencing, suggested the existence of potentially ~50 subclasses of GABAergic interneurons in the CA1 region of the mouse hippocampus alone 49 (which includes nine different clusters of PVIs). Characterizing the different classes of PVI-inhibiting interneurons and identifying the ones that are hyper-excitable in Lgdel/+ mice would be an entire study on its own and should be a focus for future research.
In conclusion, our findings provide mechanistic insights into the alterations observed at a network level in an animal model related to a human genetic disease, 22q11DS. Our work suggests that the hypo-excitability of subpopulations of inhibitory neurons (for example, PVIs) leads to an alteration of the neuronal synchronization in the hippocampus and probably in other brain areas 50 . Although the 22q11DS is a neurodevelopmental disorder, our data demonstrate that selective neuronal manipulations during adulthood are sufficient to restore functional brain dynamics and typical behavioral patterns. Furthermore, our results highlight PVIs as a valuable therapeutical target for 22q11DS and similar neuropsychiatric disorders.
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Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41593-018-0225-y. ;Lgdel/+ littermates. Animal assignment to the various experimental groups was randomized between the littermates within each cage. Thus, each cage contained all the treatments. The genotype of the animals was unknown to the experimenters during the experiments.
All animal protocols are in accordance with the Swiss Federal Act on Animal Protection, with the Swiss Animal Protection Ordinance and were approved by the University of Geneva and Geneva state ethics committees (authorization numbers: 1007/3129/0 and GE/156/14).
Chemical reagents. Carbachol (CCh) was purchased from Sigma-Aldrich. CNO was purchased from Enzo Life Sciences. A recombinant polypeptide containing the extracellular domain of beta1 NRG1P, able to cross over the brain blood barrier 53, 54 , was purchased from Propsec. Tetrodotoxin (TTX) was purchased from Latoxan. d-2-amino-5-phosphonopentanoic acid (d-AP5), 6,7-dinitroquinoxaline-2,3-dione (DNQX), and gabazine (GBZ) were purchased from Abcam Biochemicals.
AAVs. AAVs were produced by the University of North Carolina and the University of Pennsylvania vector cores. Calcium signals were detected using a recombinant AAV1.hSyn.GCaMP6s.WPRE.SV40, which enables the expression of the calcium-sensor GCaMP6s in neurons. The recombinant AAV5-hSyn-DIOhM4D(Gi)-mCherry and AAV5-hSyn-DIO-hM3D(Gq)-mCherry 55 construct were used for chemogenetic inhibition and excitation of Cre-expressing PVIs, respectively. AAV9.CAG.Flex.tdTomato.WPRE.bGH was used in order to specifically label Cre-expressing PVIs with a red fluorophore.
Slice preparation. 5-6-d-old pups were decapitated and their hippocampi were carefully removed and unfolded. Transverse hippocampal slices (400 μ m thickness) were made using a chopper (McIlwain). Slices were then maintained in an incubator at 33 °C in a culture medium as previously described 56 . Viral infection of the slices was performed 4 d after the preparation of the culture (4 d in vitro, DIV4), by putting a hydrophilic membrane (FHLC white membrane, Millipore) on the slice surface. A drop of AAV-containing solution (approximately 0.1 ml) was placed on the surface of the targeted CA1 region of the hippocampus using a pressurized glass pipette (Harvard Apparatus and Toohey Spritzer, Toohey Company). The membrane was left on the slice for 1 h in an incubator at 33 °C before being removed. Calcium imaging and patch-clamp experiments were conducted around one week after the viral infection that is from DIV11 onwards.
Calcium imaging. Slices previously infected at DIV4 with an AAV virus leading to the expression of the genetically encoded calcium sensor GCaMP6s 57 under the control of the human synapsin promoter were used. In some experiments, AAV enabling the conditional expression of either the excitatory DREADD hM3Gq or the inhibitory DREADD hM4Gi 58 or the red fluorophore tdTomato were also injected. Slices were immersed in an artificial cerebro-spinal fluid (ACSF) containing (in mM): NaCl (124), KCl (1.6), KH 2 PO 4 (1.2), MgCl 2 (1.3), CaCl 2 (2), glucose (10) , and ascorbic acid (2.0), pH 7.4, continuously oxygenated and perfused at ~22 °C using a peristaltic pump. Calcium transients were recorded using a Nipkow-type spinning disk confocal microscope (Olympus) coupled with single-photon lasers (excitation wavelength 488 and 565 nm). Images were acquired through a CCD camera (Visitron Systems Evolve). Slices were imaged using a 10 × 0.30NA objective (Olympus) at 8.9-Hz frame rate (that is, 112 ms per frame). A few calcium-imaging experiments (n = 5 WT and 9 Lgdel/+ slices) were performed using a multibeam two-photon laser scanning system (same frame rate as above, Trimscope, LaVision Biotec) mounted on a BX51WI Olympus microscope coupled to Ultra II chameleon laser (Coherent). A typical imaging session covered a field of 420-× 420-µ m size containing ~250 individual neurons in the CA1 area. Network dynamics were induced by bath application of carbachol 59, 60 . Slices were recorded for 6 min either before or 5 min after CCh application. For some experiments, slices were pre-incubated with NRG1P (10 nM) or CNO (1 µ M) 15 min before CCh application. All drugs remained present during the entire recordings.
Analyses of the calcium imaging data. Calcium data analyses 61 were performed using the Matlab-based 'Caltracer3beta' software (Columbia University), which enables the tracing of regions of interests (ROIs) matching the identified GCaMP6s-expressing neuronal soma and the calculation of the averaged fluorescence signal from each cell-based ROIs as a function of time. To distinguish the actual neuronal calcium activity from background activity (that is, fibers nearby cells), the fluorescence within a halo of the pixels surrounding the ROI was subtracted from the fluorescence signal recorded in the ROI. From the resulting signal, the onsets and offsets of the calcium events were identified. Onsets were automatically detected when fluorescence exceeded a threshold set for every slice (based on the background noise) during a minimum time of 1 s (based on the kinetics of GCaMP6s), and offsets were defined as the events half-decay time. Onsets and offsets were manually corrected after automatic detection, and used to estimate 1) the proportion of active neurons and the frequency of calcium events, 2) the amplitude and the duration of calcium events, 3) the proportion of coactivated neurons and the duration of their coactivation, and 4) the proportion of correlated pairs of neurons and their preferred lags. These analyses were performed using custom-made Matlab-based scripts.
Calcium event amplitude was calculated considering the cell fluorescence value at the onset of the event (F0) and the maximum value of fluorescence measured during the event (F), and was scored as (F -F0)/F0 in percentage. All signals below 5% were considered as noise. Calcium event duration was calculated by subtracting the offset to the onset time values. An average event amplitude and duration was calculated for each neuron in each experiment (point 2 above).
The coactivation of neurons (point 3 above) is the number of onsets over the whole population for each frame. This coactivation reached significance if its value was above the maximum number of onsets found in a surrogate population obtained by randomization. The randomization (10,000 iterations) consisted in adding a random shift (between one and the total number of frames minus one) to the onsets of each neuron; each neuron had a different shift assigned. When the shifted onsets exceeded the last frame, the difference was referenced to the first frame. This procedure maintained the same activity pattern for each neuron but scrambled the relationship between neurons. This method provided an estimate of the fraction of coactive neurons that exceeded chance levels and the fraction of frames when it occurred. Note that our method is very conservative and tends to underestimate the actual number of coactive neurons especially in synchronized populations.
The correlation between two neurons (point 4 above) was quantified as the number of onset coincidences occurring between lags spanning -20 to + 20 frames and binned into two frames. Significant correlation between two neurons occurred when the number of coincidences exceeded a chance threshold at any lag. The threshold was obtained as the maximum number of coincidences found in a surrogate population (2,000 iterations) generated by a similar randomization procedure as described in the previous paragraph. The only difference was that the random shift occurred within the range of the lags used with the exclusion of zerolag. This procedure highlights pairs of neurons that are coactive within 20 frames and that have preferred lags, usually only one, above chance.
Patch-clamp electrophysiology. Recordings were done from slices perfused with oxygenated ACSF containing (in mM): NaCl (124), KCl (1.6), NaHCO 3 (24), KH 2 PO 4 (1.2), MgCl 2 (1.3), CaCl 2 (2), glucose (10), and ascorbic acid (2.0), pH 7.4, continuously oxygenated and perfused at ~22 °C using a peristaltic pump. CA1 pyramidal cells were visually identified using infrared video microscopy. PVIs were identified by fluorescence after the infection of Pvalb cre/+ ;+ /+ and Pvalb cre/+ ;Lgdel/+ slices with AAVs (see above). We specifically recorded PVIs localized in the pyramidal layer, which are in majority basket cells 39 . For recordings in current clamp mode, cells were recorded using patch-clamp pipettes (tip resistance, 3-5 MΩ ) filled with an intracellular solution containing (in mM) 70 potassium gluconate, 70 KCl, 2 NaCl, 2 MgCl 2 , 10 Na-HEPES, 1 EGTA, 2 MgATP, and 0.3 Na 2 GTP (pH 7.3) pH adjusted with KOH (290 mOsm). For recordings performed in voltage-clamp mode, the intracellular solution contained the following (in mM): 125 CsMeSO 3 , 2 CsCl, 10 Na-HEPES, 5 EGTA, 2 MgCl 2 , and 4 MgATP. Signals were amplified using a Multiclamp 200B patch-clamp amplifier (Molecular Devices), filtered and digitized at 4 kHz with an analog-to-digital converter (Digidata 1322 A, Axon Instruments) and stored using pClamp 9 software (Axon Instruments). The analysis of electrophysiological recordings was performed using Clampfit 10.2 (Molecular Devices) and MiniAnalysis software (Synaptsoft).
Passive membrane properties were obtained immediately after membrane rupture. Series resistances (range: ~10-22 MΩ , mean ± s.d.: 16.3 ± 2.6 MΩ ) were continuously monitored and recordings were discarded when these parameters changed by > 20%. To record spontaneous and miniature inhibitory and excitatory post-synaptic currents (sIPSCs, mIPSCs, sEPSCs, and mEPSCs, respectively), cells were held at 0 mV and -75 mV, respectively (correction of the liquid junction potential included). These values were chosen accordingly to the reversion potentials of glutamatergic and GABAergic currents. Miniature currents were recorded in the presence of TTX (1 µ M). Firing pattern were assessed in current clamp mode by injecting current in 25-pA steps of 600 ms of duration starting from -50 pA to 225 pA. The firing frequency was determined at each step. For some experiments, PVIs were recorded before and 15 min after treatment with NRG1P (10 nM) or CNO (1 µ M), or a mix of AP5 (50 µ M), DNQX (10 µ M), and gabazine (10 µ M).
Surgery. Analgesic treatment (paracetamol 0.2 g/kg) was administered for 2 d before the surgery. Anesthesia was induced at 5% and maintained at 1.5-2% isoflurane (w/v) (Baxter AG). Mice were placed in a stereotaxic apparatus (Angle One) above a heating pad. Eyes were covered with ointment (Lacyvisc, Alcon) and Lidocaïne, a local analgesic, was injected below the skin overlaying the skull (subcutaneous). After exposing the skull, a craniotomy (3 mm in diameter using a biopsy punch from Miltex) was made above the hippocampus. In Pvalb cre/+ ;Lgdel/+ mice, AAV infections (0.1 µ l at 0.05 ml/min) were performed using glass micropipettes (10-15-µ m tip diameter; Drummond Scientific Company) at AP: -1.7 mm, ML: 1.0 mm bilaterally and DV: 1.5 mm relative to Bregma and the skull surface in order to target the dorsal CA1 area of the hippocampus. A few infections (0.5 µ l) were carried out using the coordinates AP: -1.5 mm, ML: 1.5 mm bilaterally and DV: 1.5 mm relative to Bregma and the skull surface. The micropipettes were left in place for 5 min after microinjection and slowly retracted (0.4 mm/min) to avoid reflux of the viral solution. In all mice used for in-vivo electrophysiological recordings, the craniotomy was covered by a glass cover slip (Ø 3 mm, Warner), which was then glued (Cyanocrylate, Cyberbond) to the skull. A ground wire was positioned a couple of millimeters posterior to the recording craniotomy at the surface of the cortex. A head-post, enabling head restraining during electrophysiological recordings 62 , was cemented to the skull using a mixture of dental cement (Jet Repair, Lang) and glue (Cyanocrylate, Cyberbond). AAVinjected mice were used either for behavioral or electrophysiological measurements at least three weeks after infection. All mice used for electrophysiological recordings had at least three days for recovery and three days of head restraining habituation 63 . After the completion of each in vivo experiment, mice were injected intraperitoneal with a lethal dose of pentobarbital (150 mg/kg) followed by intracardiac perfusion with 4% paraformaldehyde (PFA). Brains were maintained in 4% PFA for 1 d and stored in PBS for histological verification of the polytrode position and/or infection accuracy (Supplementary Fig. 7 ).
In vivo electrophysiological recordings. Animals were prepared with a subcutaneous catheter (if planned for subcutaneous injections) and then fixed to a head-restraining device as previously described 64, 65 . The cover slip protecting the brain was then taken out and the dura-mater removed under 1.5% isoflurane anesthesia. After stopping the anesthesia flux, a DiI (Thermo Fisher Scientific) covered polytrode (Buszaki 64 L; Neuronexustech) was slowly lowered (~15 min) between 1.2 and 1.7 mm DV from the surface of the cortex. Then, a period dedicated to the stabilization of the signal lasted between 10 to 20 min. Broadband signals (0.1-9,000 Hz) were acquired at 32-kHz sampling rate (Neuralynx) 66 . The first experiment consisted in recording a baseline period of 30 min followed by a subcutaneous injection of Neuregulin (NRG1P, 50 µ g/kg) and an additional hour period of drug induced neuronal activity. The second experiment consisted in injecting clozapine N-oxide (CNO, 2 mg/kg) intraperitoneal before setting up the animals in the head-restraining device. The periods considered as control and as CNO-mediated excitation effect (Fig. 6 ) consisted in 30-60 and 60-90 min postinjection, respectively. In both experiments, recordings were done for 1.5 h. After completion of the experiments, the polytrode was slowly retracted and the animals were removed from the head-restraining holders.
Analysis of the in vivo electrophysiological data. Using the Matlab environment (MathWorks), LFPs were extracted by lowpass filtering (1-90 Hz) and downsampling (200 Hz) broadband signals. After a linear detrend of the signal, the LFP for each channel was normalized using z-scores. The spectral quantities were estimated with five tapers and a time-bandwidth product of three using the available toolbox named 'Chronux' (http://chronux.org). Time-frequency power spectra (window size of 10 s stepped each 2 s) were calculated for the whole recordings. As the LFPs originating from the same shank were not independent, the median power of these LFPs was calculated to obtain a power estimate for each shank of the polytrode. Since various shanks may record different parts of CA1 with different levels of AAVs infections ( Supplementary Fig. 7c ), we analyzed each shank independently and averaged the data across shank/mouse pairs. The time frequency power spectra were divided into epochs of 30 min. Each one of these epochs was represented by the median over time at each frequency bin.
Single unit activity (SUA) was obtained using the available python-based package named 'Klusta' and 'Klustaviewa' 67 . Shortly, the broadband signal was high-pass filtered at 500 Hz and negative peaks were extracted at 2.5 (weak) and 4.0 (strong) s.d. thresholds. The waveforms around these peaks (referred to as spikes) were extracted and clustered. Then, manual spike sorting enabled the isolation of SUAs (cluster quality > 0.95 and similarities with other cluster < 0.05) and only the LFPs recorded at shanks characterized by the presence of SUAs were kept for further analyses.
Then, neural synchrony was assessed using cross-correlations between the spike trains of two SUAs. Spike cross-correlation was calculated in a similar manner as the procedure used for the correlation of calcium onsets (see above). Spike trains were binned at 20 ms and the lags ranged from -600 to 600 ms. Approximately 20% of neuronal pairs did not have coincident spiking within the chosen lag range and were excluded from the analyses. Epochs of 30 min, as described above, were used to calculate the cross-correlations. The minimum number of pairs for each epoch was set at 10 and only recordings satisfying this minimum on all epochs were kept for further analyses (714 pairs per recording on average). The significance of the cross-correlation was evaluated by creating a surrogate population (500 iterations), which consisted in shifting one spike train by a random time between -600 and 600 ms (zero excluded). The threshold for significance was set at 0.001 (refs. 68, 69 ) with a false discovery rate correction for multiple testing of neuronal pairs and a Bonferroni correction for testing multiple time lags. In general, the cross-correlograms displayed a significant central peak around zero lag that varied in width. We chose to extract the maximum percentage of correlated pairs and to use these values as an index of synchrony. In one mouse (Lgdel/+ ), the percentage of correlated neurons was above 50%, which is atypical and much higher than reported in the literature ~15% 68, 69 . This mouse was excluded from all the analyses.
Behavioral testing. All tests were performed in healthy adult mice (3-10 months old). After surgery was performed, rodents were left to rest for at least 3 weeks. Mice were habituated to a single experimenter by daily sessions of 5 min handling during the week preceding the behavioral test. To test for the influence of PV neurons on behavioral measures, vehicle (NaCl 0.9%), NRG1P (50 µ g/kg), or CNO (2 mg/kg) were administered intraperitoneal as previously described [70] [71] [72] .
OFT. OFTs were performed under room lighting conditions (~100 lx). Locomotor activity was recorded in a black Plexiglas box (43 cm L × 43 cm W × 40 cm H) over which a Camera (Panasonic SD5) was placed. Mice were positioned into the center of the arena and the distance traveled was measured during 10 min using ANYmaze software (Stoelting).
Contextual fear conditioning. Contextual fear conditioning was performed in a 15 × 18 cm cage with a metallic grid floor. The walls were covered either with black/white stripes or black circle patterns to provide two different visual contexts. Some mice performed two consecutive conditioning and testing sessions using the two visual contexts with 2 weeks of interval, in the presence or not of treatment (e.g., CNO or NRG1P). The conditioning sessions consisted in placing the mice during a total of 5 min in the cage. After 3 min, three mild electric shocks (0.8 mA, 2 s) were applied through the floor grid with an interval of 30 s. Then, mice were returned to their home cage. The next day, one testing session (5 min) was performed in the same cage but without electric shocks. Freezing behavior was identified in video recordings using Anymaze software (Stoelting) and manually verified by experimenters, who were blind to the experimental conditions.
Measure of the acoustic startle reflex and the PPI. Mice were placed into a startle apparatus (Med-Associates) consisting of a small metal and PVC cage inside a sound-attenuated chamber. Whole-body startle movements were quantified by an accelerometer mounted beneath the cage and stored by a computer using the Startle Reflex software (Med-Associates). Two loudspeakers were placed inside the sound-attenuated chamber: the first produced white noise acoustic stimuli, while the second produced a continuous 70-dB background noise throughout the test. The test began with 5-min acclimation to the apparatus, followed by presentation of different types of trials: pulse alone, prepulse alone, prepulse and pulse and no stimulus trials. Pulse-alone trials consisted of a 38-ms startle pulse at 120 dB; prepulse-alone trials consisted of an 18-ms prepulse at 74, 78, 82, or 86 dB; prepulse-pulse trials consisted of a prepulse followed by the pulse. 100 ms separated the onsets between the two stimuli; and no-stimulus trials consisted of the background noise only. The test was divided in three blocks: block 1 consisted of 10 pulse-only trials, block 2 of 84 trials presented in pseudorandom order (12 pulse-only, 12 prepulse-pulse of each intensity, 3 prepulse-only of each intensity, and 12 no-stimulus trials), and block 3 of 10 pulse-only trials.
Trials were presented in pseudorandom order, with a random intertrial interval of 10-15 s. Startle response was determined as the absolute maximum-tominimum value within 200 ms after the startle pulse onset. The entire test lasted 30 min. The percentage PPI for each prepulse intensity level was calculated as follows: [100 -100 × (mean startle amplitude of prepulse-pulse trial/mean startle amplitude of pulse-alone trials)].
Statistics. All statistical analyses were done with Matlab, Origin pro 8.0 or the Prism software. We used ANOVA and post hoc test, Kolmogorov-Smirnov test, Mann-Whitney test and paired Wilcoxon test. All tests were two-sided. Data distribution was assumed to be normal but this was not formally tested. For ANOVA, homogeneity of variance was tested using the Mauschly's sphericity test (subsequent Greenhouse-Geisser or Huynd-Feldt corrections were applied if sphericity criterion was not met). No statistical methods were used to predetermine sample sizes but our sample sizes are similar to those reported in previous publications (see main text).
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Code availability. The custom-written MATLAB scripts are available from the corresponding authors upon reasonable request.
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When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
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The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Software and code
Policy information about availability of computer code
Data collection
The calcium imaging data were collected using MetaMorph software (Molecular Devices). The patch-clamp data were collected using pClamp9 (Axon Instruments). The in-vivo electrophysiological signals were acquired using Neuralynx Co. software. Mice behaviour were recorded using Anymaze software (Stoelting).
Data analysis
Calcium data analyses were performed using the Matlab-based 'Caltracer3beta' software (Columbia University) and custom-made Matlab (MathWorks Co) -based scripts available upon reasonable request. The patch-clamp data were analysed using Clampfit 10.2 (Molecular Devices) and MiniAnalysis (Synaptsoft). The in-vivo electrophysiological data were performed using the Chronux toolbox (matlab-based) as well as custom-made Matlab (MathWorks Co) -based scripts available upon reasonable request. Single unit activity (SUA) was obtained using the available python-based package named 'Klusta' and 'Klustaviewa' (ref 67) . The analysis of mice behaviour were performed using Anymaze software (Stoelting). All statistical analyses were done using Matlab, Origin pro 8.0 or Graphpad Prism.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information. All studies must disclose on these points even when the disclosure is negative.
Sample size
Comparable sample size as in previously published studies was used.
Data exclusions No specific exclusion criterion was applied except classical histological verification of viral infection as explained in the Methods.
One aberrant recording was removed as stated in the Method part of the manuscript.
Replication
The replication of our results are presented in the study and consisted in independent experiments using similar manipulations and yielding comparable rescues of LgDel phenotypes. All attempts at replication were successful.
Randomization Animal assignment to the various experimental groups was randomized between the littermates within each cage. Thus, each cage contained all the treatments.
Blinding
The genotype of the animals was unknown to the experimenters during the electrophysiological recordings, during the behavioral testings and during calcium imaging.
